Hinge Health (HNGE) Agrees To Acquire A Digestive Care Company And Enters GI Care
Article excerpt
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Hinge Health (NYSE:HNGE) has agreed to acquire Cylinder Health, a virtual first digestive healthcare company. The deal marks Hinge Health's entry into gastrointestinal care alongside its musculoskeletal and migraine services. The company plans to launch an integrated Gastrointestinal Care Program as part of its broader digital health offering. For investors watching how digital health platforms expand into multi condition care and use data and software to support that shift, it can be useful to compare Hinge Health with a wider group of companies focused on similar themes through 42 healthcare AI stocks Hinge Health sits in the growing group of digital health platforms that focus on specific conditions and sell primarily to employers and health plans. The stock trades at $80.79, with a year to date return of 77.3% and a 1 year return of 33.9%. The share price has moved around in the short term, with a 7 day gain of 7.6% and a 30 day decline of 9.5%. We've flagged 0 risks for Hinge Health. See which could impact your investment. For Hinge Health, adding Cylinder Health brings gastrointestinal care alongside its existing musculoskeletal and migraine programs. All three are sold to the same buyers, mainly employers and health plans, and can sit on the same software...
Keep reading with a free account
The rest of this article, and every signal for Hinge Health, is in your free account.
Extracted from this sentence
The acquisition news arrives just after Hinge Health reported second quarter sales of US$212.82 million and net income of US$43.69 million, compared with a net loss a year earlier.